Effects of recombinant human growth hormone on anorexic nile crocodiles (Crocodylus niloticus)

dc.contributor.author	Kanui, Titus I.
dc.contributor.author	Kimwelea, Charles N.
dc.contributor.author	Aulie, Arnfinn
dc.date.accessioned	2015-01-20T08:59:32Z
dc.date.available	2015-01-20T08:59:32Z
dc.date.issued	1992-07
dc.identifier.citation	Comparative Biochemistry and Physiology Part A: Physiology Volume 102, Issue 3, July 1992, Pages 553–557	en_US
dc.identifier.uri	http://www.sciencedirect.com/science/article/pii/0300962992902088
dc.identifier.uri	http://hdl.handle.net/123456789/643
dc.description	doi:10.1016/0300-9629(92)90208-8	en_US
dc.description.abstract	1. Eleven-month-old Nile crocodiles with poor appetite and retarded growth were injected with 0.325 μg/g recombinant human growth hormone (hGH) twice a week for 4 weeks. 2. The treated animals had a mean intake per meal of 29.8 g/kg, while the controls ate only 2.8 g/kg. 3. The treated group gained 8.1% of their initial body weight, while the controls lost 6.3%. 4. During 4 weeks of treatment the body and head length increased by 3.93 and 1.29%, respectively, while no linear growth took place in the controls. 5. The treated group had higher contents of skeletal muscle protein and liver glycogen than the control group. 6. In conclusion, recombinant hGH induces appetite and growth in anorexic crocodiles.	en_US
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.title	Effects of recombinant human growth hormone on anorexic nile crocodiles (Crocodylus niloticus)	en_US
dc.type	Article	en_US